JPH0367072B2 - - Google Patents
Info
- Publication number
- JPH0367072B2 JPH0367072B2 JP58137917A JP13791783A JPH0367072B2 JP H0367072 B2 JPH0367072 B2 JP H0367072B2 JP 58137917 A JP58137917 A JP 58137917A JP 13791783 A JP13791783 A JP 13791783A JP H0367072 B2 JPH0367072 B2 JP H0367072B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- ethanol
- formula
- methyl
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 6
- 238000006297 dehydration reaction Methods 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- NIGNBCLEMMGDQP-UHFFFAOYSA-N 1-benzothiepine Chemical compound S1C=CC=CC2=CC=CC=C12 NIGNBCLEMMGDQP-UHFFFAOYSA-N 0.000 claims description 2
- RBIZGRHTTSFDPW-UHFFFAOYSA-N 10-(1-methylpiperidin-4-yl)-5h-thieno[2,3-c][2]benzothiepin-10-ol Chemical compound C1CN(C)CCC1C1(O)C2=CC=CC=C2CSC2=C1C=CS2 RBIZGRHTTSFDPW-UHFFFAOYSA-N 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims 1
- ZCQVEMXIVISDLV-UHFFFAOYSA-M magnesium;1-methylpiperidin-4-ide;chloride Chemical compound [Mg+2].[Cl-].CN1CC[CH-]CC1 ZCQVEMXIVISDLV-UHFFFAOYSA-M 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 48
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- 239000000203 mixture Substances 0.000 description 17
- 230000000694 effects Effects 0.000 description 14
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 150000001414 amino alcohols Chemical class 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 239000012452 mother liquor Substances 0.000 description 5
- FIADGNVRKBPQEU-UHFFFAOYSA-N pizotifen Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CCC2=C1C=CS2 FIADGNVRKBPQEU-UHFFFAOYSA-N 0.000 description 5
- 229960004572 pizotifen Drugs 0.000 description 5
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 4
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 4
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000000739 antihistaminic agent Substances 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 4
- 229960003147 reserpine Drugs 0.000 description 4
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 4
- 239000007818 Grignard reagent Substances 0.000 description 3
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 3
- 206010044565 Tremor Diseases 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 230000001387 anti-histamine Effects 0.000 description 3
- 230000000794 anti-serotonin Effects 0.000 description 3
- 239000003420 antiserotonin agent Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- -1 diaryl ketone Chemical class 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 150000004795 grignard reagents Chemical class 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VZWWTHTUQTYAGH-UHFFFAOYSA-N 1-methyl-4-(5h-thieno[2,3-c][2]benzothiepin-10-ylidene)piperidine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CSC2=C1C=CS2 VZWWTHTUQTYAGH-UHFFFAOYSA-N 0.000 description 2
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical group CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- MYGXGCCFTPKWIH-UHFFFAOYSA-N 4-chloro-1-methylpiperidine Chemical compound CN1CCC(Cl)CC1 MYGXGCCFTPKWIH-UHFFFAOYSA-N 0.000 description 2
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 2
- 229940000681 5-hydroxytryptophan Drugs 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 238000003747 Grignard reaction Methods 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- 206010020843 Hyperthermia Diseases 0.000 description 2
- 206010058667 Oral toxicity Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001705 anti-serotonergic effect Effects 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000036031 hyperthermia Effects 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 231100000418 oral toxicity Toxicity 0.000 description 2
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 2
- CSUUDNFYSFENAE-UHFFFAOYSA-N (2-methoxyphenyl)-phenylmethanone Chemical compound COC1=CC=CC=C1C(=O)C1=CC=CC=C1 CSUUDNFYSFENAE-UHFFFAOYSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000009132 Catalepsy Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- RSDOPYMFZBJHRL-UHFFFAOYSA-N Oxotremorine Chemical compound O=C1CCCN1CC#CCN1CCCC1 RSDOPYMFZBJHRL-UHFFFAOYSA-N 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- RGCVKNLCSQQDEP-UHFFFAOYSA-N Perphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 RGCVKNLCSQQDEP-UHFFFAOYSA-N 0.000 description 1
- IUJDSEJGGMCXSG-UHFFFAOYSA-N Thiopental Chemical compound CCCC(C)C1(CC)C(=O)NC(=S)NC1=O IUJDSEJGGMCXSG-UHFFFAOYSA-N 0.000 description 1
- 206010047853 Waxy flexibility Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003270 anti-cataleptic effect Effects 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000000891 anti-reserpine Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 229940124433 antimigraine drug Drugs 0.000 description 1
- 150000008365 aromatic ketones Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000013404 behavioral symptom Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 1
- 229960001140 cyproheptadine Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005837 enolization reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical group C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000006742 locomotor activity Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- FYYHWMGAXLPEAU-IGMARMGPSA-N magnesium-24 Chemical compound [24Mg] FYYHWMGAXLPEAU-IGMARMGPSA-N 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229960000762 perphenazine Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- XRXDAJYKGWNHTQ-UHFFFAOYSA-N quipazine Chemical compound C1CNCCN1C1=CC=C(C=CC=C2)C2=N1 XRXDAJYKGWNHTQ-UHFFFAOYSA-N 0.000 description 1
- 229950002315 quipazine Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical class OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 229960003279 thiopental Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001562 ulcerogenic effect Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ã次åŒïŒ
ãæããïŒâïŒïŒâã¡ãã«âïŒâãããªãžãªãã³ïŒ
âïŒïŒïŒâãžãããããšãïŒïŒïŒïŒâïŒâïŒâ
ãã³ãŸããšãã³ããã³ãã®ïŒïŒïŒé ç³é žå¡©ã®è£œæ³
ã«é¢ããã åŒã®ååç©ïŒãããã¢ãã³ïŒããã³ãã®
ïŒïŒïŒé ç³é žåºã¯é«åºŠã®æãã¹ã¿ãã³äœçšãæã»
ãããã³äœçšãæã¬ã»ã«ãã³äœçšããã³æã«ã¿ã¬
ãã·ãŒäœçšãæããæŽã«ãããã¯æ¯èŒçã«äœæ¯æ§
ã§ããããçé çã®æ²»çã®çšéãæåŸ ãããŠã
ãã åèšååç©ã¯ïŒïŒïŒé ç³é žå¡©ã®åœ¢ã§è¬çåŠç
ã«è©Šéšãã該塩ãåŸå£ããã³éåŸå£æäžãããæ
äžéã¯å¡©åºã«å¯Ÿãèšç®ãããå€ãã®è¬çè©Šéšã«ã
ãããã®å¹æã¯ãã€ããã©ãã³ã°ã«ãŒãã®äžå¡ç°
ã®ææå¶å€ã®å¹æã«é¡äŒŒããŠããïŒè©²ååç©ã¯ã
ãŠã¹ã«ãããŠã¬ã»ã«ãã³ã«å¯Ÿãæ®æçã«äœçšã
ïŒè©²ååç©ã¯ïŒmgïŒKgïŒi.p.ïŒã®æäžéã§ã¬ã»ã«ã
ã³äœæž©ç°åžžéäžã«èãããæ®æããïŒããã³ã©ã
ãã«ãããŠã¬ã»ã«ãã³ã«æ®æãïŒ20mgïŒKgã®ç®äž
æäžããå§ããŠã該ååç©ã¯ã¬ã»ã«ãã³ã®æœ°çèª
çºäœçšãæºè¶³çã«èãããæå¶ããïŒãæŽã«ã©ã
ãã«ãããŠèãããæçãªæã«ã¿ã¬ãã·ãŒäœçšã
æãïŒãã«ããšããžã³ïŒperphenazineïŒã«ã¿ã¬
ãã·ãŒã®è©Šéšã«ãããŠãã®äžäœä¿è·çšéPD50ã¯
7.0mgïŒKgïŒs.c.ïŒã§ããïŒãæŽã«åããŠã¹ã«ãã
ãŠãªããœãã¬ã¢ãªã³æ¯ããã«æ®æããïŒæ¯ããã
èãããæå¶ããéå€çšéã¯1.0mgïŒKgïŒi.p.ïŒã§
ãããããã«å ããŠãååç©ïŒ©ã¯æçœãªäžæ¢ã®æ
ã»ãããã³äœçšãæããŠããïŒãã®æ§è³ªã¯ïŒâã
ãããã·ããªãããã¢ã³ãã©ããã«æäžããããš
ã«ããèªèµ·ãããè¡åã«åœ±é¿ããããšã«ããã家
å ã«ãããŠãããžã³ïŒquipazineïŒéæž©çã«ãã
圱é¿ãäžããããšã«ãããæŽã«ããçšåºŠãŸã§ã©ã
ãã«ãããŠããªãã¿ãã³ãšçžäºäœçšããããšã«ã
ãã瀺ããããïŒâããããã·ããªãããã¢ã³ã
ã©ããã«æäžåŸãååç©ã®è¡åçè¡çŸ€ã«å¯Ÿãã
äžæ¢æã»ãããã³äœçšã®åŒ·åºŠããæ¯ããã«å¯Ÿã
ïŒ2.9mgïŒKgïŒäžäœä¿è·çšéïŒç®äžæäžã§PD50ïŒã§
è¡šããæŽã«åè¢ã®åçŽéåïŒãã¿ããã³ã°ãïŒïŒ2.6
mgïŒKgïŒã§è¡šãããããã®è©Šéšã«ãããååç©
ã®äœçšã¯ããµã€ããããã¿ãžã³ã®ããã«é¡äŒŒããŠ
ããæŽã«ã¢ãããªãããªã³ã®äœçšãããæ¬è³ªçã«
ãã匷ãã ååç©ã®æãã¹ã¿ãã³ããã³æã»ãããã³äœ
çšã¯ãã®æ«æ¢¢æ§ã®äœçšã®å ã§æã匷åã§ãããã¢
ã«ã¢ããã«çµå£æäžããå Žåãäžäœä¿è·çšé
PD50ãšããŠè¡šãããããã¹ã¿ãã³ãšã¢ãŸãŒã«è©Š
éšã«ãããæãã¹ã¿ãã³äœçšã¯0.046mgïŒKgã§ã
ãããã¹ã¿ãã³è§£æ¯ããã³ãã¹ã¿ãã³æ°ç®¡æ¯ççª
è©Šéšã«ãããŠãååç©ã¯æã匷åãªå ¬ç¥ã®æã
ã¹ã¿ãã³å€ã«å±ãããïŒâããããã·ããªãã¿ã
ã³ã®æäžåŸãã©ããã®è¢æµ®è «è©Šéšã«ãããæã»ã
ããã³äœçšã¯ã0.3mgïŒKgã®çµå£æäžåŸçµ±èšçæ
矩ããããååç©ã¯åã¯æž©åãªæ«æ¢¢æ§ã®æã³ãª
ã³äœçšãæããŠããïŒè©²ååç©ã¯ããŠã¹ã«ãããŠ
ç³åæ£å€§äœçšã瀺ããããŠã¢ã«ã¢ããã«ãããŠã¢
ã»ãã«ã³ãªã³ã®å±æäœçšãããæããã å ¬ç¥ã®æçé çå€ããŸãããšã³ïŒãã€ããœã³
ïŒDixonïŒçãArzneim.âForsch.27ã1968ã
1977ïŒãšæ¯èŒããŠãååç©ã¯ãã®ããäœãææ
å¶äœçšã«ãããŠæçœãªå©ç¹ãæããŠãããçµå£æ
äžããå Žåãååç©ã¯ãã€ã¶ãŒïŒBossierïŒã
ãã³ã·ãŒã¢ã³ïŒSimonïŒã«ãã芳å¯è©Šéšã§ããŠã¹
ã®æ¢æ»æŽ»æ§ãããŸãã€ããšã³ã®1/3æå¶ããïŒå
åç©ã®D50ã¯23mgïŒKgã§ãããããŸãããšã³ã®
D50ã¯ïŒmgïŒKgã§ããïŒããã€ãŠã¹ïŒDewsïŒã«ã
ãå âã»ã«æ³ãçšããããŠã¹ã®èªçºéå掻æ§è©Šéš
ã«ãããŠãååç©ã®æå¶æŽ»æ§ã¯ããŸãããšã³ã®
äœçšãããïŒåäœãïŒååç©ã®D50ã¯24.2mgïŒ
Kgã§ãããããŸãããšã³D50ã¯3.4mgïŒKgã§ããïŒã
ããŠã¹ã«ãããããªãã³ã¿ãŒã«ã®ç¡ç çžä¹äœçšã®
匱ç¹ç°æ§è©Šéšã«ãããŠãååç©ã®éå€éã¯ãã®
çµå£LD50ã®10ïŒ ã«å¯Ÿå¿ããäžæ¹ããŸãããšã³ã®
éå€çšéã¯ãã®çµå£LD50ã®ããã2.5ïŒ ã§ãã
ïŒããŠã¹ã«ãããäºçš®ã®ååç©ã®çµå£æ¯æ§ã¯é¡äŒŒ
ããŠããïŒãååç©ã¯ã©ããã«ãããŠè¡ååºæ¿
ã«å¯ŸãæçœãªåŸåãæãïŒã¢ãã¡ãã¯ã¹
ïŒanimexïŒåšæ©ãçšããåç©ã®å šæŽ»æ§ã«å¯Ÿããã
ã®å¹æã芳å¯ããå Žåãååç©ã®10mgïŒKgãã
ã³30mgïŒKgã®çµå£æäžéã¯æž©åãªåºæ¿äœçšãæã
ïŒåç©ã®æŽ»æ§ã¯å¯Ÿç §çŸ€ã®125ã131ïŒ ã®å€ã«å¢å ã
ãïŒãäžæ¹ããŸãããšã³ã®ïŒã30mgïŒKgã®çµå£æ
äžéã¯åç©ã®ç·æŽ»æ§ã®çµ±èšçæ矩ãæããã«ç€ºã
ãŠããïŒå¯Ÿç §çŸ€ã«æ¯èŒããŠ57ã64ïŒ ã®å€ãŸã§ïŒã ã©ããã«ãããååç©ã®çµå£æ¯æ§ã¯é©ãã¹ã
çšäœãïŒïŒïœïŒKgïŒp.o.ïŒã®æäžéã§æäžãã
åŸãåå¹ã®è©ŠéšçŸ€ãããã äžå¹ã®åç©ãïŒæ¥ä»¥å
ã«æ»äº¡ããªãã€ããæäžåŸã30åéå ã§ç©ãããª
æå¶ã®ã¿ã芳å¯ããããããŠã¹ã«ãããŠçµå£
LD50ã¯129mgïŒKgã§ãããååç©ã50ã100
mgïŒKgã®æäžéã§ã®ç¬ã«å¯Ÿããåäžæäžã¯äœãã®
è¡åã®å€åãæ¯æ§çºçŸåã¯åç©ã®æ»ãåŒãããã
ãªãã åŒã§è¡šããããååç©ã¯æç®ã«èšèŒãããŠã
ãïŒRajsãner M.ãMetysã J.and Protiua M.ã
Collect.Czech.Chem.Commun.32ã2854ã1967ïŒ
ïŒããšã³ã¹ãããã¢ç¹èš±ç¬¬115241å·ïŒã該ååç©
ã¯ãããã©ããããã©ã³äžå¡©åïŒâã¡ãã«âïŒâ
ãããªãžã«ã¢ã°ãã·ãŠã ãšããšãïŒïŒïŒïŒâïŒ
âïŒâãã³ãŸããšãã³âïŒïŒ9HïŒâãªã³ãšåå¿ã
ããåŒãç¶ãåŸãããåŒïŒ ã®ïŒâïŒïŒâã¡ãã«âïŒâãããªãžã«ïŒâïŒïŒïŒâ
ãžãããããšãïŒïŒïŒïŒâïŒâïŒâãã³ãŸããš
ãã³âïŒâãªãŒã«ã®é žæ§è§Šåªè±æ°Žåå¿ã«ãã€ãŠåŸ
ãããã åœæ以äžã®å 容ã芳å¯ãããŠããïŒããªãã¡ã
74ïŒ ã®åçã§ã°ãªãã€ãŒã«åå¿ããåŸããããšèš
ãããååç©ã¯å質ã§ã¯ãªããç¶ããŠè¡ãªãã
ãé žè§Šåªè±æ°ŽäžïŒåžç¡«é žã§å ç±ïŒæªå€åã®ãŸãŸæ®
åããä»ã®ååç©ã§çžåœã«æ±æããåŸã€ãŠæçµç
æç©ãããªãã¡ååç©ã¯éåžžã«æ±æãããŠã
ããå ã«ã®ã¹ãè«æäžã§å ±åãããè±æ°Žã®åç95
ïŒ ã¯èžçºæ®çç©ãããªãã¡ç²ååç©ã«é¢ããã
ã®ã§ããã該ç²ååç©ã¯äžç¢ºå®ã®äžèšäžçŽç©ãå«
æããŠãããåŸãããçæç©ã®äžçŽç©ã¯åååç©
ã«å¯Ÿãå ±åãããäœèç¹ïŒãã³ãŒã³âç³æ²¹ãšãŒ
ãã«ãã125âæŽã«ã¢ã»ãã³ãã119ã120âïŒã«
察ããŠã説æã§ããããããã®äœèç¹çæç©ã¯æº¶
åªåããŠãããšèããããïŒãããããå®éã¯ã
ããã®ååç©ãšå ã«ã®ã¹ãäžçŽç©ãšã®æ··åç©ã§
ãã€ãã ããã©ããããã©ã³äžãããšãïŒïŒïŒïŒâïŒ
âïŒâãã³ãŸããšãã³âïŒïŒ9HïŒâãªã³ãšå¡©åïŒ
âã¡ãã«âïŒâãããªãžã«ãã°ãã·ãŠã ãšã®åå¿
ã¯æè¿ãã詳现ã«ç ç 究ãããæŽã«åŸãããç²ç
æç©ã¯çµæ¶åããã³ã¯ãããã°ã©ãã€ãŒæ³ã®çµå
ããã«ããåé¢ãããã·ãªã«ã²ã«ãçšããèå±€ã¯
ãããã°ã©ãã€ãŒæ³ãçšããåŸãããç©è³ªã¯ãã
ãäžå質ã®ããã«æãããããŠã¢ããã¢ã«ã³ãŒã«
ã«å ããŠããã極æ§ã®å°ããæåãå®è³ªçéã§
å«æããŠããããã«æããããçŽç²ãªã¢ããã¢ã«
ã³ãŒã«ã¯è©²ç²çæç©ãããšã¿ããŒã«ãšã®æœåºã«
ãã€ãŠåŸãããšãã§ãïŒææã®ååç©ã¯æªæº¶è§£
ã®ãŸãŸæ®ããäžæ¹ããå°ãã極æ§ã®ç©è³ªã¯æº¶æ¶²å
ã«å ¥ããåŸè ã®ç©è³ªã¯ã·ãªã«ã²ã«ãçšããã«ã©ã
ã¯ãããã°ã©ãã€ãŒæ³ã«ããæ¯æ¶²ããåé¢ã次ã
ã§çµæ¶åã«ãã粟補ã§ãããã¢ããã¢ã«ã³ãŒã«
ãšæ¥µæ§ã®å°ããæåã®åæ¹ã212ã213âã®å枩床
ã§æ£ç¢ºã«æº¶èããããšã¯æãé©ãã¹ãã§ãããã
ããã«ãããã®æ··åç©ã¯ãçžåœã®éäžããã€ãŠè
解ãã次ãã§ãããã¯äžèšæç®äžã§å ±åãããåŠ
ã溶åªåã®èç¹ã§ããã ãã極æ§ã®å°ããæåã®å çŽ åæã¯ã¢ããã¢ã«
ã³ãŒã«ã®å çŽ åæã«æ¥µããŠé¡äŒŒããçµæã瀺ã
ããã©ãããã¹ã¹ãã¯ãã«ã¯ãã®æ£ç¢ºãªçµæ
C17H16NOS2ã蚌æããããã¯ã¢ããã¢ã«ã³ãŒã«
ãããïŒåã®æ°ŽçŽ ååã®å°ãªãçµæã®æåã«å¯Ÿ
å¿ãããæ°èŠååç©ã®çŽ«å€ã¹ãã¯ãã«ã¯é«çšåºŠã®
å ±åœ¹ã瀺ããããã¯ãžã¢ãªãŒã«ã±ãã³æ§é ã«å¯Ÿå¿
ãããèµ€å€ã¹ãã¯ãã«ã¯1611cm-1ã®ç¹æ§åžåãã³
ãã«ãã€ãŠãžã¢ãªãŒã«ã±ãã³ã確èªããŠãããèµ€
å€ããã³ 1H NMRã¹ãã¯ãã«ã®åæ¹ã¯æ°Žé žåºã®
äžååšãå®èšŒããŠãããååç©ããã³æ¥µæ§ã®å°
ãªãç©è³ªã® 1H NMRã¹ãã¯ãã«ã«ãããå·®ç°
ã¯ãè³éŠæãããã³ã®ã·ã°ãã«åž¯åã«ãããŠç¹ã«
æ矩ããããååç©ã®ã¹ãã¯ãã«ã¯å åã®è³éŠ
æãããã³ã®ååšã瀺ãããã©ãããã®å ïŒåã®
ã·ã°ãã«ã¯æªå解å€éé ã«å䜵ãããããŠéªšæ Œã®
ïŒäœã«ããããããã³ã®ã·ã°ãã«ã®ã¿ãæ確ã«å
é¢ãã極æ§ã®å°ããååç©ã® 1H NMRã¯ïŒåã®
è³éŠæãããã³ã®ã¿ã®ååšã説æãããã®ã·ã°ã
ã«ã¯å šãŠæ確ã«åºå¥ãããããŠéªšæ Œã®åã ã®äœçœ®
ã«å±åšåã§ããïŒäœã®ãããã³ã¯ååšããªããå
åç©ãšæ¥µæ§ã®å°ããæåéã®æ§é äžã®å·®ç°ã®å¥
ã®èšŒæã¯ãã©ã°ã¡ã³ãã«å¯Ÿå¿ããé åã«ãããã
ã¹ã¹ãã¯ãã«ã«ãã€ãŠäžãããããååç©ã®äž»
ãã©ã°ã¡ã³ãã¯ïœïŒz98ãæããããã¯ä¿è·ãã
ãïŒâã¡ãã«ãããªãžã³æ§é ãæããã¢ã³ã¢ããŠ
ã ã€ãªã³ã«å¯Ÿå¿ãã極æ§ã®å°ããäžçŽç©ã®äž»ãã©
ã°ã¡ã³ãã¯ïœïŒz70ãæãïŒããã¯ïŒåã®ççŽ å
åã§ã¡ãã«ãããªãžã³ãã©ã°ã¡ã³ãã«å¯Ÿå¿ããã
第äžã®ã±ãŒã¹ã¯èèªæççŽ ã«çµåããã¡ãã«ãã
ãªãžã«åºã«å¯Ÿãå žåœ¢çã§ããã第äºã®ã±ãŒã¹ã¯è³
éŠæççŽ ååã«çµåããã¡ãã«ãããªãžã«åºã®æ
åã«å¯Ÿå¿ãããå šãŠãããã®ã¹ãã¯ãã«ã¯æ¥µæ§ã®
å°ããååç©ã«å¯ŸããåŒ ã®ïŒâïŒïŒâã¡ãã«âïŒâãããªãžã«ïŒããšã
ïŒïŒïŒïŒâïŒâïŒâãã³ãŸããšãã³âïŒïŒ9HïŒâ
ãªã³ã®æ§é ãäžããã ååç©ã®åœ¢æã¯åºçºã±ãã³ïŒã±ãåºïŒ£ïŒïŒã®
äºéçµåãå«ããŠïŒã®ååå ã®äžåã®äºéçµåç³»
ã«ã°ãªãã€ãŒã«è©Šè¬ã®ïŒïŒïŒâä»å ã«ãã€ãŠèª¬æ
ã§ããããåã¯çšããåå¿æ¡ä»¶äžåºçºã±ãã³ã®åŒ·
å¶ãšããŒã«åã«ãã€ãŠåœ¢æããå極åã«å¯Ÿããå
èšã°ãªãã€ãŒã«è©Šè¬ã®ä»å ã«ãã€ãŠèª¬æã§ãã
ïŒGaerther R.ãChem.Revs.45ã493ã1949ïŒãã
ã®ãããªä»å ããã³åŒãç¶ãã®å æ°Žå解ã¯ïŒåã®
æ°ŽçŽ ååã®è±é¢ã«ãããããªãã¡é žåã«ãããã
ããã空æ°äžã®é žçŽ äœçšã®ããšã§è¡ãªãããªãã
ã°ãªããªãã€ããããã¯äœã芳å¯ãããªãåå¿äŸ
ã§ããããããã¯ç«äœçã«åŒ·ãé害ãããè³éŠæ
ã±ãã³ãäŸãã°ïŒïŒïŒïŒïŒïŒïŒâããã©ã¡ãã«ã
ãã³ïŒïŒïŒïŒïŒïŒïŒâããã©ã¡ãã«â2â²âã¡ãã
ã·ãã³ãŸããšãã³ãšã°ãªãã€ã«è©Šè¬ãšã®åå¿ã«ã
ããŠå ã«ç 究ãããïŒFuson R.C.çïŒJ.Amer.
Chem.Soc.65ã60ã1943ïŒ71ã2543ã1949ïŒJ.
Org.Chem.13ã496ã1948ïŒã æ¬çºæã®äž»é¡ã¯ååç©ã®è£œé æ¹æ³ãæäŸãã
ããšã«ããããã®æ¹æ³ã¯ã¢ããã¢ã«ã³ãŒã«ãã
ååç©ãé€å»ãããã次ãã§æ®ã©çŽç²ãªç¶æ ã§
ãããè±æ°Žåå¿ã«çšããæ¹æ³ããã³ããã«ããå
åç©ã®æ®çç©ã®æ®ã©å šãŠãé€å»ããæ¹æ³ãå«
ãããããã®éèŠãªä»å çæäœã¯ãšã¿ããŒã«äžã§
ååç©ã®è¯å¥œãªæº¶è§£æ§ãå©çšããã第äžã®åå¿
å·¥çšãããªãã¡ã°ãªãã€ãŒã«åå¿ã®çæç©ããšã¿
ããŒã«ã«æžæ¿ãããæžæ¿æ¶²ã沞ç¹ã«å ç±ã次ãã§
å·åŽåŸæ®ã©çŽç²ãªã¢ããã¢ã«ã³ãŒã«ãåžåŒãé
ããããã®ç©è³ªã¯çŽ50ïŒ ã®åçã§åŸããïŒçžåœé
ã®ååç©ãå«æããæ¯æ¶²ã¯ææã®ã¢ããã¢ã«ã³
ãŒã«äžéäœãæŽã«çµæžçã«ã¯ååããããªãã
ååç©ã®æçµã®æ®çç©ã¯ãšã¿ããŒã«ããçµæ¶å
ã«ãã€ãŠæçµçæç©ããé€å»ããïŒãã®äžçŽç©
ã¯æ¯æ¶²äžã«æ®ããæåŸã«ãæ¬çºæã®æ§æéšåã¯æ°Ž
æ§ãšã¿ããŒã«äžïŒïŒïŒé ç³é žã§äžåããããšã«ã
ãååç©ã®æ°èŠãªé ç³é žå¡©ã補é ããæ¹æ³ã«ã
ãã容æã«çµæ¶åããïŒïŒïŒé ç³é žå¡©ã¯æ°Žã«äžçš
床ã«å¯æº¶ã§ããããããŠä»ã®é žä»å å¡©ãããæçµ
æäžåœ¢æ ã®è£œé ã«å¯Ÿãã¯ããã«é©ããŠããïŒä»ã®
é žä»å¡©ã¯ã³ãã¯é žå¡©ãããã«é žå¡©ããã³ãã¬ã€ã³
é žå¡©ã§ããããããã¯ãã§ã«é瀺ãããŠãã
ïŒRajsãner M.çI.C.åç §ïŒãçŽç²ãªç¶æ ã§ååç©
ã補é ããæ¹æ³ã¯ãããã§ã¯èšèŒãããŠããªãã
ãªããªããããã¯æ¬çºæã«å«ãŸããŠããªãããã§
ããã ãã®çºæã«ããã°ãååç©ã¯ä»¥äžã®å®æœäŸã®
æé ã«ãã奜éœåã«è£œé ããããšãã§ããããã
ãããã®äŸã¯äœãæ¬çºæã®ç¯å²ãéå®ãããã®ã§
ã¯ãªãã 也ç¥ããã©ããããã©ã³50mlããã°ãã·ãŠã 24
ïœã«æ·»å ã次ãã§ïŒâã¯ããâïŒâã¡ãã«ãããª
ãžã³ïŒAdlerovaÂŽ et al.ãCesk.farm.12ã122ã
1963ïŒã也ç¥ããã©ããããã©ã³ïŒã¢ã¬ããŠã©ã·
ãŒãPotasit 4Aã§ä¹Ÿç¥ïŒ300mlã«æº¶è§£ããçŽ25ïŒ
ã®æº¶æ¶²ãå°å ¥ãã次ãã§50ã55âã®æž©åºŠã«äºç±ã
ã油济äžã§æ··åç©ãå æž©ããããšãŠçŽ ïŒ0.5ïœïŒ
ããã³ïŒïŒïŒâãžããã¢ãšã¿ã³ïŒmlãæ·»å ã次ã
ã§åå¿ãéå§ãããŸã§æ··åç©ãçŽ10ã30åæŸçœ®ã
ããæ··åç©ãæ¿ããéæµãå§ãããšã油济ãåã
é€ã次ãã§ïŒâã¯ããâïŒâã¡ãã«ãããªãžã³æº¶
液ã®æ®éšåããåå¿æ··åç©ãæ¿ããéæµãç¶ãã
ãããªé床ã§æ»Žäžãããåå¿ãååãªé床ã§éå§
ãå§ãããšãæ¹æãéå§ãããçŽ40ã50ååŸã倧
éšåã®æº¶æ¶²ã滎äžãããšããåå¿æ··åç©ãäžçšåºŠ
ã«å æž©ãããæ¹æããªããæŽã«1.5æééæµãç¶
ç¶ããã次ãã§æ··åç©ãæ°·æ°Žã§10âã«å·åŽããå®
åžžæ¹æããã³æ°·æ°Žå·åŽäžã也ç¥ããã©ããããã©
ã³325mlã«æº¶è§£ããããšãïŒïŒïŒïŒâïŒâïŒâã
ã³ãŸããšãã³âïŒâïŒ9HïŒâãªã³ïŒProtiva M.ã
Rajsãner M.çãCollect.Czech.Chem.Commun.
29ã2161ã1964ïŒ39ã1366ã1974ïŒ155ïœã®æº¶æ¶²
ãçšããŠïŒæéå ã§åŠçãããåå¿æ··åç©ã10ã
15âã®æž©åºŠã§ç¶æããã溶液ãå®å šã«æ»Žäžãã
ããå·åŽãäžæ¢ã次ãã§è©²æº¶æ¶²ãèªç¶ã«å®€æž©ã«ãª
ããŸã§æ··åç©ãçŽ30åéæ¹æãããåŸãããæè²
溶液ããæ¿ããæ¹æããªãããæ··åç©ã®æž©åºŠã20
âãè¶ ããªããããªé床ã§ïŒæåã¯éäžçãªå€éš
å·åŽãå¿ èŠã§ããïŒãæ°ŽïŒã«æº¶è§£ããïŒïŒïŒé
ç³é ž225ïœã®æº¶æ¶²ã§åŠçããããããåŸããã«ãš
ã³500mlãæ·»å ã次ãã§æ··åç©ã10åéæ¿ããæ¹
æããã次ãã§äžæ§ç©è³ªãå«æãããã«ãšã³å±€ã
åé¢ããæ°Žå±€éšåããã«ãšã³200mlã§æŽæµããã¯
ãããã«ã 9600mlãæ·»å ã次ãã§æ¿ããæ¹æãã
ã€å·åŽããªãããæ¿ã¢ã³ã¢ãã¢æ°Žã§ã¢ã«ã«ãªæ§ã«
ãããã¯ãããã«ã å±€ãåé¢ããæ°Žå±€éšåãã¯ã
ããã«ã 200mlã§æœåºã次ãã§äžç·ã«ããã¯ãã
ãã«ã 溶液ãæ°Ž300mlã§æŽæµã次ãã§ç¡æ°Žçé žã«
ãªãŠã 30ïœããã³æŽ»æ§ç10ïœã§12æéæŸçœ®ããã
次ãã§åºäœãå¥ã次ãã§ã¯ãããã«ã 500mlã§
æŽæµãããã¯ãããã«ã ãæžå§äžïŒ10ã20kPaïŒ
ã§èžæºå»ããæ®çç©ããšã¿ããŒã«200mlã§åžé
ãã次ãã§æ··åç©ãçæééæµã次ãã§50âã«å·
åŽãããæ²æ®¿ããçµæ¶ïŒâïŒïŒâã¡ãã«âïŒâã
ããªãžã«ïŒâïŒïŒïŒâãžãããããšãïŒïŒïŒïŒâ
ïŒâïŒâãã³ãŸããšãã³âïŒâãªãŒã«ïŒïŒã
åžåŒãéãããšã¿ããŒã«100ml次ãã§ç³æ²¹ãšãŒã
ã«100mlã§é£ç¶çã«æŽæµããæŽã«æžå§äžå®€æž©ã§ä¹Ÿ
ç¥ãããåçã¯113ïœïŒ51ïŒ ïŒã§ãããçæç©ã¯
209ã211âã§è解ãããåŸãããç©è³ªã¯æ®ã©çŽç²
ã§ããã以åŸã®åŠçã«å šãå®å®ã§ããããšã¿ããŒ
ã«ããè©Šæã®çµæ¶åã«ãããèç¹212ã213âãæ
ããå®å šã«çŽç²ãªç©è³ªãåŸãã æ°Ž1170mlã«æº¶è§£ããç¡«é ž240ïœã®æº¶æ¶²ããå ã®
ã¢ããã¢ã«ã³ãŒã«166ïœãçšããŠ40ã50âã§åŠ
çã次ãã§æ··åç©ãæ¹æããªãã15åééæµã
ããå·åŽåŸãæ··åç©ãæ°Ž200mlã§åžéããã¯ãã
ãã«ã 400mlãæ·»å ãã次ãã§æ¿ã¢ã«ã«ãªæ§ã¢ã³
ã¢ãã¢220ïœãæ·»å ããªããæ¹æããæ··åç©ãã¢
ã«ã«ãªæ§ã«ãããæ··åç©ã枩床ã20ã30âã«ä¿æ
ãããã¯ãããã«ã å±€ãåé¢ãã次ãã§æ°Žå±€éšå
ãã¯ãããã«ã ïŒÃ100mlã§æœåºãããäžç·ã«ã
ãã¯ãããã«ã 溶液ãæ°Ž150mlã§æŽæµããçé žã«
ãªãŠã 20ïœã§ä¹Ÿç¥ãã次ãã§äžæŒå€æŸçœ®åŸä¹Ÿç¥å€
ãå¥ããã液ãæž©åãªæžå§äžïŒ10ã20kPaïŒ
ã§èžçºãããçµæ¶æ§æ®çç©ããšã¿ããŒã«900mlã§
åŠçã次ãã§æ¹æããªãã沞ç¹ãŸã§å ç±ããããš
ã«ãã溶解ããã溶液ãå ç±ããªãããæšç10ïœ
ãçšããŠéããããšã«ãã溶液ãè±è²ãã次ã
液ãïŒâã§çµæ¶åãããã12æéæŸçœ®åŸãïŒâ
ïŒïŒâã¡ãã«âïŒâãããªãžãªãã³ïŒâïŒïŒïŒâãž
ãããããšãâïŒïŒïŒïŒâïŒâïŒâãã³ãŸããšã
ã³ïŒïŒã®çµæ¶åããå¡©åºãåžåŒããŠéã次ãã§
ãšã¿ããŒã«50mlæŽã«ç³æ²¹ãšãŒãã«100mlã§é£ç¶ç
ã«æŽæµããã宀枩ã§ä¹Ÿç¥ããçæç©124ïœãåŸãã
æ¯æ¶²ã200mlã®å®¹éãŸã§èžçºãã次ãã§ïŒâã§æŸ
眮ãããšæºè¶³ã§ããçŽåºŠãæããçæç©14ïœïŒç¬¬
äºã®åç©«ç©ïŒãåŸããå šäœã®åçã¯138ïœïŒ88ïŒ ïŒ
ã§ãããèç¹ã¯160ã161âã§ãããå šéã®ç©è³ªã
ãã®åŸã®å¡©ãžã®å€æã«é©åœã§ãããè©ŠæãæŽã«çµ
æ¶åãããšãèç¹162ã164âãæããå®å šã«çŽç²
ãªå¡©åºãåŸãããã å¡©åºïŒ94ïœïŒãç ®æ²žãšã¿ããŒã«650mlã«æº¶è§£
ããã溶解åŸãå ç±ãäžæ¢ã次ãã§æ°Ž85mlã«æº¶è§£
ããïŒïŒïŒé ç³é ž47ïœã®ç±æº¶æ¶²ããã€ããæ·»å ã
ãã次ãã§åŸããã溶液ãæ¹æããªãã10âã«å·
åŽãçµæ¶åãèªèµ·ããã12æéå·ååŸãçµæ¶ãåž
åŒããŠéã次ãã§ãšã¿ããŒã«ïŒÃ50mlã§æŽæµã
ãã湿最çæç©ãããšã¿ããŒã«1250mlããã³æ°Ž
1000mlã®æ··åç©äžã§æ²žç¹æž©åºŠã«å ç±ããŠæº¶è§£ãã
次ãã§ç±çç¶æ ãä¿ã¡ãªãã溶液ããéãæŽã«ã
éã氷济äžã§ïŒæéæ¹æããã³å·åŽãçµæ¶åãã
ããã次ãã§çæç©ããšã¿ããŒã«ïŒÃ30mlã§æŽæµ
ã宀枩ã§ç©ºæ°äžã§ä¹Ÿç¥ãããæ¯æ¶²ãæžå§äžïŒïŒã
5kPaïŒã§æåã®å®¹ç©ã®çŽååãŸã§èžçºããã次
ãã§ïŒâã«å·åŽãçæç©ã®ç¬¬äºã®åç©«ç©ãåŸãã
å šäœã®åçã¯ãå¡©åºã®ïŒïŒïŒé ç³å¡©é žã®125ïœ
ïŒ90ïŒ ïŒã§ãããå¡©ã¯228ã231âã§è解ïŒå解ã
䌎ãïŒããã
âïŒïŒïŒâãžãããããšãïŒïŒïŒïŒâïŒâïŒâ
ãã³ãŸããšãã³ããã³ãã®ïŒïŒïŒé ç³é žå¡©ã®è£œæ³
ã«é¢ããã åŒã®ååç©ïŒãããã¢ãã³ïŒããã³ãã®
ïŒïŒïŒé ç³é žåºã¯é«åºŠã®æãã¹ã¿ãã³äœçšãæã»
ãããã³äœçšãæã¬ã»ã«ãã³äœçšããã³æã«ã¿ã¬
ãã·ãŒäœçšãæããæŽã«ãããã¯æ¯èŒçã«äœæ¯æ§
ã§ããããçé çã®æ²»çã®çšéãæåŸ ãããŠã
ãã åèšååç©ã¯ïŒïŒïŒé ç³é žå¡©ã®åœ¢ã§è¬çåŠç
ã«è©Šéšãã該塩ãåŸå£ããã³éåŸå£æäžãããæ
äžéã¯å¡©åºã«å¯Ÿãèšç®ãããå€ãã®è¬çè©Šéšã«ã
ãããã®å¹æã¯ãã€ããã©ãã³ã°ã«ãŒãã®äžå¡ç°
ã®ææå¶å€ã®å¹æã«é¡äŒŒããŠããïŒè©²ååç©ã¯ã
ãŠã¹ã«ãããŠã¬ã»ã«ãã³ã«å¯Ÿãæ®æçã«äœçšã
ïŒè©²ååç©ã¯ïŒmgïŒKgïŒi.p.ïŒã®æäžéã§ã¬ã»ã«ã
ã³äœæž©ç°åžžéäžã«èãããæ®æããïŒããã³ã©ã
ãã«ãããŠã¬ã»ã«ãã³ã«æ®æãïŒ20mgïŒKgã®ç®äž
æäžããå§ããŠã該ååç©ã¯ã¬ã»ã«ãã³ã®æœ°çèª
çºäœçšãæºè¶³çã«èãããæå¶ããïŒãæŽã«ã©ã
ãã«ãããŠèãããæçãªæã«ã¿ã¬ãã·ãŒäœçšã
æãïŒãã«ããšããžã³ïŒperphenazineïŒã«ã¿ã¬
ãã·ãŒã®è©Šéšã«ãããŠãã®äžäœä¿è·çšéPD50ã¯
7.0mgïŒKgïŒs.c.ïŒã§ããïŒãæŽã«åããŠã¹ã«ãã
ãŠãªããœãã¬ã¢ãªã³æ¯ããã«æ®æããïŒæ¯ããã
èãããæå¶ããéå€çšéã¯1.0mgïŒKgïŒi.p.ïŒã§
ãããããã«å ããŠãååç©ïŒ©ã¯æçœãªäžæ¢ã®æ
ã»ãããã³äœçšãæããŠããïŒãã®æ§è³ªã¯ïŒâã
ãããã·ããªãããã¢ã³ãã©ããã«æäžããããš
ã«ããèªèµ·ãããè¡åã«åœ±é¿ããããšã«ããã家
å ã«ãããŠãããžã³ïŒquipazineïŒéæž©çã«ãã
圱é¿ãäžããããšã«ãããæŽã«ããçšåºŠãŸã§ã©ã
ãã«ãããŠããªãã¿ãã³ãšçžäºäœçšããããšã«ã
ãã瀺ããããïŒâããããã·ããªãããã¢ã³ã
ã©ããã«æäžåŸãååç©ã®è¡åçè¡çŸ€ã«å¯Ÿãã
äžæ¢æã»ãããã³äœçšã®åŒ·åºŠããæ¯ããã«å¯Ÿã
ïŒ2.9mgïŒKgïŒäžäœä¿è·çšéïŒç®äžæäžã§PD50ïŒã§
è¡šããæŽã«åè¢ã®åçŽéåïŒãã¿ããã³ã°ãïŒïŒ2.6
mgïŒKgïŒã§è¡šãããããã®è©Šéšã«ãããååç©
ã®äœçšã¯ããµã€ããããã¿ãžã³ã®ããã«é¡äŒŒããŠ
ããæŽã«ã¢ãããªãããªã³ã®äœçšãããæ¬è³ªçã«
ãã匷ãã ååç©ã®æãã¹ã¿ãã³ããã³æã»ãããã³äœ
çšã¯ãã®æ«æ¢¢æ§ã®äœçšã®å ã§æã匷åã§ãããã¢
ã«ã¢ããã«çµå£æäžããå Žåãäžäœä¿è·çšé
PD50ãšããŠè¡šãããããã¹ã¿ãã³ãšã¢ãŸãŒã«è©Š
éšã«ãããæãã¹ã¿ãã³äœçšã¯0.046mgïŒKgã§ã
ãããã¹ã¿ãã³è§£æ¯ããã³ãã¹ã¿ãã³æ°ç®¡æ¯ççª
è©Šéšã«ãããŠãååç©ã¯æã匷åãªå ¬ç¥ã®æã
ã¹ã¿ãã³å€ã«å±ãããïŒâããããã·ããªãã¿ã
ã³ã®æäžåŸãã©ããã®è¢æµ®è «è©Šéšã«ãããæã»ã
ããã³äœçšã¯ã0.3mgïŒKgã®çµå£æäžåŸçµ±èšçæ
矩ããããååç©ã¯åã¯æž©åãªæ«æ¢¢æ§ã®æã³ãª
ã³äœçšãæããŠããïŒè©²ååç©ã¯ããŠã¹ã«ãããŠ
ç³åæ£å€§äœçšã瀺ããããŠã¢ã«ã¢ããã«ãããŠã¢
ã»ãã«ã³ãªã³ã®å±æäœçšãããæããã å ¬ç¥ã®æçé çå€ããŸãããšã³ïŒãã€ããœã³
ïŒDixonïŒçãArzneim.âForsch.27ã1968ã
1977ïŒãšæ¯èŒããŠãååç©ã¯ãã®ããäœãææ
å¶äœçšã«ãããŠæçœãªå©ç¹ãæããŠãããçµå£æ
äžããå Žåãååç©ã¯ãã€ã¶ãŒïŒBossierïŒã
ãã³ã·ãŒã¢ã³ïŒSimonïŒã«ãã芳å¯è©Šéšã§ããŠã¹
ã®æ¢æ»æŽ»æ§ãããŸãã€ããšã³ã®1/3æå¶ããïŒå
åç©ã®D50ã¯23mgïŒKgã§ãããããŸãããšã³ã®
D50ã¯ïŒmgïŒKgã§ããïŒããã€ãŠã¹ïŒDewsïŒã«ã
ãå âã»ã«æ³ãçšããããŠã¹ã®èªçºéå掻æ§è©Šéš
ã«ãããŠãååç©ã®æå¶æŽ»æ§ã¯ããŸãããšã³ã®
äœçšãããïŒåäœãïŒååç©ã®D50ã¯24.2mgïŒ
Kgã§ãããããŸãããšã³D50ã¯3.4mgïŒKgã§ããïŒã
ããŠã¹ã«ãããããªãã³ã¿ãŒã«ã®ç¡ç çžä¹äœçšã®
匱ç¹ç°æ§è©Šéšã«ãããŠãååç©ã®éå€éã¯ãã®
çµå£LD50ã®10ïŒ ã«å¯Ÿå¿ããäžæ¹ããŸãããšã³ã®
éå€çšéã¯ãã®çµå£LD50ã®ããã2.5ïŒ ã§ãã
ïŒããŠã¹ã«ãããäºçš®ã®ååç©ã®çµå£æ¯æ§ã¯é¡äŒŒ
ããŠããïŒãååç©ã¯ã©ããã«ãããŠè¡ååºæ¿
ã«å¯ŸãæçœãªåŸåãæãïŒã¢ãã¡ãã¯ã¹
ïŒanimexïŒåšæ©ãçšããåç©ã®å šæŽ»æ§ã«å¯Ÿããã
ã®å¹æã芳å¯ããå Žåãååç©ã®10mgïŒKgãã
ã³30mgïŒKgã®çµå£æäžéã¯æž©åãªåºæ¿äœçšãæã
ïŒåç©ã®æŽ»æ§ã¯å¯Ÿç §çŸ€ã®125ã131ïŒ ã®å€ã«å¢å ã
ãïŒãäžæ¹ããŸãããšã³ã®ïŒã30mgïŒKgã®çµå£æ
äžéã¯åç©ã®ç·æŽ»æ§ã®çµ±èšçæ矩ãæããã«ç€ºã
ãŠããïŒå¯Ÿç §çŸ€ã«æ¯èŒããŠ57ã64ïŒ ã®å€ãŸã§ïŒã ã©ããã«ãããååç©ã®çµå£æ¯æ§ã¯é©ãã¹ã
çšäœãïŒïŒïœïŒKgïŒp.o.ïŒã®æäžéã§æäžãã
åŸãåå¹ã®è©ŠéšçŸ€ãããã äžå¹ã®åç©ãïŒæ¥ä»¥å
ã«æ»äº¡ããªãã€ããæäžåŸã30åéå ã§ç©ãããª
æå¶ã®ã¿ã芳å¯ããããããŠã¹ã«ãããŠçµå£
LD50ã¯129mgïŒKgã§ãããååç©ã50ã100
mgïŒKgã®æäžéã§ã®ç¬ã«å¯Ÿããåäžæäžã¯äœãã®
è¡åã®å€åãæ¯æ§çºçŸåã¯åç©ã®æ»ãåŒãããã
ãªãã åŒã§è¡šããããååç©ã¯æç®ã«èšèŒãããŠã
ãïŒRajsãner M.ãMetysã J.and Protiua M.ã
Collect.Czech.Chem.Commun.32ã2854ã1967ïŒ
ïŒããšã³ã¹ãããã¢ç¹èš±ç¬¬115241å·ïŒã該ååç©
ã¯ãããã©ããããã©ã³äžå¡©åïŒâã¡ãã«âïŒâ
ãããªãžã«ã¢ã°ãã·ãŠã ãšããšãïŒïŒïŒïŒâïŒ
âïŒâãã³ãŸããšãã³âïŒïŒ9HïŒâãªã³ãšåå¿ã
ããåŒãç¶ãåŸãããåŒïŒ ã®ïŒâïŒïŒâã¡ãã«âïŒâãããªãžã«ïŒâïŒïŒïŒâ
ãžãããããšãïŒïŒïŒïŒâïŒâïŒâãã³ãŸããš
ãã³âïŒâãªãŒã«ã®é žæ§è§Šåªè±æ°Žåå¿ã«ãã€ãŠåŸ
ãããã åœæ以äžã®å 容ã芳å¯ãããŠããïŒããªãã¡ã
74ïŒ ã®åçã§ã°ãªãã€ãŒã«åå¿ããåŸããããšèš
ãããååç©ã¯å質ã§ã¯ãªããç¶ããŠè¡ãªãã
ãé žè§Šåªè±æ°ŽäžïŒåžç¡«é žã§å ç±ïŒæªå€åã®ãŸãŸæ®
åããä»ã®ååç©ã§çžåœã«æ±æããåŸã€ãŠæçµç
æç©ãããªãã¡ååç©ã¯éåžžã«æ±æãããŠã
ããå ã«ã®ã¹ãè«æäžã§å ±åãããè±æ°Žã®åç95
ïŒ ã¯èžçºæ®çç©ãããªãã¡ç²ååç©ã«é¢ããã
ã®ã§ããã該ç²ååç©ã¯äžç¢ºå®ã®äžèšäžçŽç©ãå«
æããŠãããåŸãããçæç©ã®äžçŽç©ã¯åååç©
ã«å¯Ÿãå ±åãããäœèç¹ïŒãã³ãŒã³âç³æ²¹ãšãŒ
ãã«ãã125âæŽã«ã¢ã»ãã³ãã119ã120âïŒã«
察ããŠã説æã§ããããããã®äœèç¹çæç©ã¯æº¶
åªåããŠãããšèããããïŒãããããå®éã¯ã
ããã®ååç©ãšå ã«ã®ã¹ãäžçŽç©ãšã®æ··åç©ã§
ãã€ãã ããã©ããããã©ã³äžãããšãïŒïŒïŒïŒâïŒ
âïŒâãã³ãŸããšãã³âïŒïŒ9HïŒâãªã³ãšå¡©åïŒ
âã¡ãã«âïŒâãããªãžã«ãã°ãã·ãŠã ãšã®åå¿
ã¯æè¿ãã詳现ã«ç ç 究ãããæŽã«åŸãããç²ç
æç©ã¯çµæ¶åããã³ã¯ãããã°ã©ãã€ãŒæ³ã®çµå
ããã«ããåé¢ãããã·ãªã«ã²ã«ãçšããèå±€ã¯
ãããã°ã©ãã€ãŒæ³ãçšããåŸãããç©è³ªã¯ãã
ãäžå質ã®ããã«æãããããŠã¢ããã¢ã«ã³ãŒã«
ã«å ããŠããã極æ§ã®å°ããæåãå®è³ªçéã§
å«æããŠããããã«æããããçŽç²ãªã¢ããã¢ã«
ã³ãŒã«ã¯è©²ç²çæç©ãããšã¿ããŒã«ãšã®æœåºã«
ãã€ãŠåŸãããšãã§ãïŒææã®ååç©ã¯æªæº¶è§£
ã®ãŸãŸæ®ããäžæ¹ããå°ãã極æ§ã®ç©è³ªã¯æº¶æ¶²å
ã«å ¥ããåŸè ã®ç©è³ªã¯ã·ãªã«ã²ã«ãçšããã«ã©ã
ã¯ãããã°ã©ãã€ãŒæ³ã«ããæ¯æ¶²ããåé¢ã次ã
ã§çµæ¶åã«ãã粟補ã§ãããã¢ããã¢ã«ã³ãŒã«
ãšæ¥µæ§ã®å°ããæåã®åæ¹ã212ã213âã®å枩床
ã§æ£ç¢ºã«æº¶èããããšã¯æãé©ãã¹ãã§ãããã
ããã«ãããã®æ··åç©ã¯ãçžåœã®éäžããã€ãŠè
解ãã次ãã§ãããã¯äžèšæç®äžã§å ±åãããåŠ
ã溶åªåã®èç¹ã§ããã ãã極æ§ã®å°ããæåã®å çŽ åæã¯ã¢ããã¢ã«
ã³ãŒã«ã®å çŽ åæã«æ¥µããŠé¡äŒŒããçµæã瀺ã
ããã©ãããã¹ã¹ãã¯ãã«ã¯ãã®æ£ç¢ºãªçµæ
C17H16NOS2ã蚌æããããã¯ã¢ããã¢ã«ã³ãŒã«
ãããïŒåã®æ°ŽçŽ ååã®å°ãªãçµæã®æåã«å¯Ÿ
å¿ãããæ°èŠååç©ã®çŽ«å€ã¹ãã¯ãã«ã¯é«çšåºŠã®
å ±åœ¹ã瀺ããããã¯ãžã¢ãªãŒã«ã±ãã³æ§é ã«å¯Ÿå¿
ãããèµ€å€ã¹ãã¯ãã«ã¯1611cm-1ã®ç¹æ§åžåãã³
ãã«ãã€ãŠãžã¢ãªãŒã«ã±ãã³ã確èªããŠãããèµ€
å€ããã³ 1H NMRã¹ãã¯ãã«ã®åæ¹ã¯æ°Žé žåºã®
äžååšãå®èšŒããŠãããååç©ããã³æ¥µæ§ã®å°
ãªãç©è³ªã® 1H NMRã¹ãã¯ãã«ã«ãããå·®ç°
ã¯ãè³éŠæãããã³ã®ã·ã°ãã«åž¯åã«ãããŠç¹ã«
æ矩ããããååç©ã®ã¹ãã¯ãã«ã¯å åã®è³éŠ
æãããã³ã®ååšã瀺ãããã©ãããã®å ïŒåã®
ã·ã°ãã«ã¯æªå解å€éé ã«å䜵ãããããŠéªšæ Œã®
ïŒäœã«ããããããã³ã®ã·ã°ãã«ã®ã¿ãæ確ã«å
é¢ãã極æ§ã®å°ããååç©ã® 1H NMRã¯ïŒåã®
è³éŠæãããã³ã®ã¿ã®ååšã説æãããã®ã·ã°ã
ã«ã¯å šãŠæ確ã«åºå¥ãããããŠéªšæ Œã®åã ã®äœçœ®
ã«å±åšåã§ããïŒäœã®ãããã³ã¯ååšããªããå
åç©ãšæ¥µæ§ã®å°ããæåéã®æ§é äžã®å·®ç°ã®å¥
ã®èšŒæã¯ãã©ã°ã¡ã³ãã«å¯Ÿå¿ããé åã«ãããã
ã¹ã¹ãã¯ãã«ã«ãã€ãŠäžãããããååç©ã®äž»
ãã©ã°ã¡ã³ãã¯ïœïŒz98ãæããããã¯ä¿è·ãã
ãïŒâã¡ãã«ãããªãžã³æ§é ãæããã¢ã³ã¢ããŠ
ã ã€ãªã³ã«å¯Ÿå¿ãã極æ§ã®å°ããäžçŽç©ã®äž»ãã©
ã°ã¡ã³ãã¯ïœïŒz70ãæãïŒããã¯ïŒåã®ççŽ å
åã§ã¡ãã«ãããªãžã³ãã©ã°ã¡ã³ãã«å¯Ÿå¿ããã
第äžã®ã±ãŒã¹ã¯èèªæççŽ ã«çµåããã¡ãã«ãã
ãªãžã«åºã«å¯Ÿãå žåœ¢çã§ããã第äºã®ã±ãŒã¹ã¯è³
éŠæççŽ ååã«çµåããã¡ãã«ãããªãžã«åºã®æ
åã«å¯Ÿå¿ãããå šãŠãããã®ã¹ãã¯ãã«ã¯æ¥µæ§ã®
å°ããååç©ã«å¯ŸããåŒ ã®ïŒâïŒïŒâã¡ãã«âïŒâãããªãžã«ïŒããšã
ïŒïŒïŒïŒâïŒâïŒâãã³ãŸããšãã³âïŒïŒ9HïŒâ
ãªã³ã®æ§é ãäžããã ååç©ã®åœ¢æã¯åºçºã±ãã³ïŒã±ãåºïŒ£ïŒïŒã®
äºéçµåãå«ããŠïŒã®ååå ã®äžåã®äºéçµåç³»
ã«ã°ãªãã€ãŒã«è©Šè¬ã®ïŒïŒïŒâä»å ã«ãã€ãŠèª¬æ
ã§ããããåã¯çšããåå¿æ¡ä»¶äžåºçºã±ãã³ã®åŒ·
å¶ãšããŒã«åã«ãã€ãŠåœ¢æããå極åã«å¯Ÿããå
èšã°ãªãã€ãŒã«è©Šè¬ã®ä»å ã«ãã€ãŠèª¬æã§ãã
ïŒGaerther R.ãChem.Revs.45ã493ã1949ïŒãã
ã®ãããªä»å ããã³åŒãç¶ãã®å æ°Žå解ã¯ïŒåã®
æ°ŽçŽ ååã®è±é¢ã«ãããããªãã¡é žåã«ãããã
ããã空æ°äžã®é žçŽ äœçšã®ããšã§è¡ãªãããªãã
ã°ãªããªãã€ããããã¯äœã芳å¯ãããªãåå¿äŸ
ã§ããããããã¯ç«äœçã«åŒ·ãé害ãããè³éŠæ
ã±ãã³ãäŸãã°ïŒïŒïŒïŒïŒïŒïŒâããã©ã¡ãã«ã
ãã³ïŒïŒïŒïŒïŒïŒïŒâããã©ã¡ãã«â2â²âã¡ãã
ã·ãã³ãŸããšãã³ãšã°ãªãã€ã«è©Šè¬ãšã®åå¿ã«ã
ããŠå ã«ç 究ãããïŒFuson R.C.çïŒJ.Amer.
Chem.Soc.65ã60ã1943ïŒ71ã2543ã1949ïŒJ.
Org.Chem.13ã496ã1948ïŒã æ¬çºæã®äž»é¡ã¯ååç©ã®è£œé æ¹æ³ãæäŸãã
ããšã«ããããã®æ¹æ³ã¯ã¢ããã¢ã«ã³ãŒã«ãã
ååç©ãé€å»ãããã次ãã§æ®ã©çŽç²ãªç¶æ ã§
ãããè±æ°Žåå¿ã«çšããæ¹æ³ããã³ããã«ããå
åç©ã®æ®çç©ã®æ®ã©å šãŠãé€å»ããæ¹æ³ãå«
ãããããã®éèŠãªä»å çæäœã¯ãšã¿ããŒã«äžã§
ååç©ã®è¯å¥œãªæº¶è§£æ§ãå©çšããã第äžã®åå¿
å·¥çšãããªãã¡ã°ãªãã€ãŒã«åå¿ã®çæç©ããšã¿
ããŒã«ã«æžæ¿ãããæžæ¿æ¶²ã沞ç¹ã«å ç±ã次ãã§
å·åŽåŸæ®ã©çŽç²ãªã¢ããã¢ã«ã³ãŒã«ãåžåŒãé
ããããã®ç©è³ªã¯çŽ50ïŒ ã®åçã§åŸããïŒçžåœé
ã®ååç©ãå«æããæ¯æ¶²ã¯ææã®ã¢ããã¢ã«ã³
ãŒã«äžéäœãæŽã«çµæžçã«ã¯ååããããªãã
ååç©ã®æçµã®æ®çç©ã¯ãšã¿ããŒã«ããçµæ¶å
ã«ãã€ãŠæçµçæç©ããé€å»ããïŒãã®äžçŽç©
ã¯æ¯æ¶²äžã«æ®ããæåŸã«ãæ¬çºæã®æ§æéšåã¯æ°Ž
æ§ãšã¿ããŒã«äžïŒïŒïŒé ç³é žã§äžåããããšã«ã
ãååç©ã®æ°èŠãªé ç³é žå¡©ã補é ããæ¹æ³ã«ã
ãã容æã«çµæ¶åããïŒïŒïŒé ç³é žå¡©ã¯æ°Žã«äžçš
床ã«å¯æº¶ã§ããããããŠä»ã®é žä»å å¡©ãããæçµ
æäžåœ¢æ ã®è£œé ã«å¯Ÿãã¯ããã«é©ããŠããïŒä»ã®
é žä»å¡©ã¯ã³ãã¯é žå¡©ãããã«é žå¡©ããã³ãã¬ã€ã³
é žå¡©ã§ããããããã¯ãã§ã«é瀺ãããŠãã
ïŒRajsãner M.çI.C.åç §ïŒãçŽç²ãªç¶æ ã§ååç©
ã補é ããæ¹æ³ã¯ãããã§ã¯èšèŒãããŠããªãã
ãªããªããããã¯æ¬çºæã«å«ãŸããŠããªãããã§
ããã ãã®çºæã«ããã°ãååç©ã¯ä»¥äžã®å®æœäŸã®
æé ã«ãã奜éœåã«è£œé ããããšãã§ããããã
ãããã®äŸã¯äœãæ¬çºæã®ç¯å²ãéå®ãããã®ã§
ã¯ãªãã 也ç¥ããã©ããããã©ã³50mlããã°ãã·ãŠã 24
ïœã«æ·»å ã次ãã§ïŒâã¯ããâïŒâã¡ãã«ãããª
ãžã³ïŒAdlerovaÂŽ et al.ãCesk.farm.12ã122ã
1963ïŒã也ç¥ããã©ããããã©ã³ïŒã¢ã¬ããŠã©ã·
ãŒãPotasit 4Aã§ä¹Ÿç¥ïŒ300mlã«æº¶è§£ããçŽ25ïŒ
ã®æº¶æ¶²ãå°å ¥ãã次ãã§50ã55âã®æž©åºŠã«äºç±ã
ã油济äžã§æ··åç©ãå æž©ããããšãŠçŽ ïŒ0.5ïœïŒ
ããã³ïŒïŒïŒâãžããã¢ãšã¿ã³ïŒmlãæ·»å ã次ã
ã§åå¿ãéå§ãããŸã§æ··åç©ãçŽ10ã30åæŸçœ®ã
ããæ··åç©ãæ¿ããéæµãå§ãããšã油济ãåã
é€ã次ãã§ïŒâã¯ããâïŒâã¡ãã«ãããªãžã³æº¶
液ã®æ®éšåããåå¿æ··åç©ãæ¿ããéæµãç¶ãã
ãããªé床ã§æ»Žäžãããåå¿ãååãªé床ã§éå§
ãå§ãããšãæ¹æãéå§ãããçŽ40ã50ååŸã倧
éšåã®æº¶æ¶²ã滎äžãããšããåå¿æ··åç©ãäžçšåºŠ
ã«å æž©ãããæ¹æããªããæŽã«1.5æééæµãç¶
ç¶ããã次ãã§æ··åç©ãæ°·æ°Žã§10âã«å·åŽããå®
åžžæ¹æããã³æ°·æ°Žå·åŽäžã也ç¥ããã©ããããã©
ã³325mlã«æº¶è§£ããããšãïŒïŒïŒïŒâïŒâïŒâã
ã³ãŸããšãã³âïŒâïŒ9HïŒâãªã³ïŒProtiva M.ã
Rajsãner M.çãCollect.Czech.Chem.Commun.
29ã2161ã1964ïŒ39ã1366ã1974ïŒ155ïœã®æº¶æ¶²
ãçšããŠïŒæéå ã§åŠçãããåå¿æ··åç©ã10ã
15âã®æž©åºŠã§ç¶æããã溶液ãå®å šã«æ»Žäžãã
ããå·åŽãäžæ¢ã次ãã§è©²æº¶æ¶²ãèªç¶ã«å®€æž©ã«ãª
ããŸã§æ··åç©ãçŽ30åéæ¹æãããåŸãããæè²
溶液ããæ¿ããæ¹æããªãããæ··åç©ã®æž©åºŠã20
âãè¶ ããªããããªé床ã§ïŒæåã¯éäžçãªå€éš
å·åŽãå¿ èŠã§ããïŒãæ°ŽïŒã«æº¶è§£ããïŒïŒïŒé
ç³é ž225ïœã®æº¶æ¶²ã§åŠçããããããåŸããã«ãš
ã³500mlãæ·»å ã次ãã§æ··åç©ã10åéæ¿ããæ¹
æããã次ãã§äžæ§ç©è³ªãå«æãããã«ãšã³å±€ã
åé¢ããæ°Žå±€éšåããã«ãšã³200mlã§æŽæµããã¯
ãããã«ã 9600mlãæ·»å ã次ãã§æ¿ããæ¹æãã
ã€å·åŽããªãããæ¿ã¢ã³ã¢ãã¢æ°Žã§ã¢ã«ã«ãªæ§ã«
ãããã¯ãããã«ã å±€ãåé¢ããæ°Žå±€éšåãã¯ã
ããã«ã 200mlã§æœåºã次ãã§äžç·ã«ããã¯ãã
ãã«ã 溶液ãæ°Ž300mlã§æŽæµã次ãã§ç¡æ°Žçé žã«
ãªãŠã 30ïœããã³æŽ»æ§ç10ïœã§12æéæŸçœ®ããã
次ãã§åºäœãå¥ã次ãã§ã¯ãããã«ã 500mlã§
æŽæµãããã¯ãããã«ã ãæžå§äžïŒ10ã20kPaïŒ
ã§èžæºå»ããæ®çç©ããšã¿ããŒã«200mlã§åžé
ãã次ãã§æ··åç©ãçæééæµã次ãã§50âã«å·
åŽãããæ²æ®¿ããçµæ¶ïŒâïŒïŒâã¡ãã«âïŒâã
ããªãžã«ïŒâïŒïŒïŒâãžãããããšãïŒïŒïŒïŒâ
ïŒâïŒâãã³ãŸããšãã³âïŒâãªãŒã«ïŒïŒã
åžåŒãéãããšã¿ããŒã«100ml次ãã§ç³æ²¹ãšãŒã
ã«100mlã§é£ç¶çã«æŽæµããæŽã«æžå§äžå®€æž©ã§ä¹Ÿ
ç¥ãããåçã¯113ïœïŒ51ïŒ ïŒã§ãããçæç©ã¯
209ã211âã§è解ãããåŸãããç©è³ªã¯æ®ã©çŽç²
ã§ããã以åŸã®åŠçã«å šãå®å®ã§ããããšã¿ããŒ
ã«ããè©Šæã®çµæ¶åã«ãããèç¹212ã213âãæ
ããå®å šã«çŽç²ãªç©è³ªãåŸãã æ°Ž1170mlã«æº¶è§£ããç¡«é ž240ïœã®æº¶æ¶²ããå ã®
ã¢ããã¢ã«ã³ãŒã«166ïœãçšããŠ40ã50âã§åŠ
çã次ãã§æ··åç©ãæ¹æããªãã15åééæµã
ããå·åŽåŸãæ··åç©ãæ°Ž200mlã§åžéããã¯ãã
ãã«ã 400mlãæ·»å ãã次ãã§æ¿ã¢ã«ã«ãªæ§ã¢ã³
ã¢ãã¢220ïœãæ·»å ããªããæ¹æããæ··åç©ãã¢
ã«ã«ãªæ§ã«ãããæ··åç©ã枩床ã20ã30âã«ä¿æ
ãããã¯ãããã«ã å±€ãåé¢ãã次ãã§æ°Žå±€éšå
ãã¯ãããã«ã ïŒÃ100mlã§æœåºãããäžç·ã«ã
ãã¯ãããã«ã 溶液ãæ°Ž150mlã§æŽæµããçé žã«
ãªãŠã 20ïœã§ä¹Ÿç¥ãã次ãã§äžæŒå€æŸçœ®åŸä¹Ÿç¥å€
ãå¥ããã液ãæž©åãªæžå§äžïŒ10ã20kPaïŒ
ã§èžçºãããçµæ¶æ§æ®çç©ããšã¿ããŒã«900mlã§
åŠçã次ãã§æ¹æããªãã沞ç¹ãŸã§å ç±ããããš
ã«ãã溶解ããã溶液ãå ç±ããªãããæšç10ïœ
ãçšããŠéããããšã«ãã溶液ãè±è²ãã次ã
液ãïŒâã§çµæ¶åãããã12æéæŸçœ®åŸãïŒâ
ïŒïŒâã¡ãã«âïŒâãããªãžãªãã³ïŒâïŒïŒïŒâãž
ãããããšãâïŒïŒïŒïŒâïŒâïŒâãã³ãŸããšã
ã³ïŒïŒã®çµæ¶åããå¡©åºãåžåŒããŠéã次ãã§
ãšã¿ããŒã«50mlæŽã«ç³æ²¹ãšãŒãã«100mlã§é£ç¶ç
ã«æŽæµããã宀枩ã§ä¹Ÿç¥ããçæç©124ïœãåŸãã
æ¯æ¶²ã200mlã®å®¹éãŸã§èžçºãã次ãã§ïŒâã§æŸ
眮ãããšæºè¶³ã§ããçŽåºŠãæããçæç©14ïœïŒç¬¬
äºã®åç©«ç©ïŒãåŸããå šäœã®åçã¯138ïœïŒ88ïŒ ïŒ
ã§ãããèç¹ã¯160ã161âã§ãããå šéã®ç©è³ªã
ãã®åŸã®å¡©ãžã®å€æã«é©åœã§ãããè©ŠæãæŽã«çµ
æ¶åãããšãèç¹162ã164âãæããå®å šã«çŽç²
ãªå¡©åºãåŸãããã å¡©åºïŒ94ïœïŒãç ®æ²žãšã¿ããŒã«650mlã«æº¶è§£
ããã溶解åŸãå ç±ãäžæ¢ã次ãã§æ°Ž85mlã«æº¶è§£
ããïŒïŒïŒé ç³é ž47ïœã®ç±æº¶æ¶²ããã€ããæ·»å ã
ãã次ãã§åŸããã溶液ãæ¹æããªãã10âã«å·
åŽãçµæ¶åãèªèµ·ããã12æéå·ååŸãçµæ¶ãåž
åŒããŠéã次ãã§ãšã¿ããŒã«ïŒÃ50mlã§æŽæµã
ãã湿最çæç©ãããšã¿ããŒã«1250mlããã³æ°Ž
1000mlã®æ··åç©äžã§æ²žç¹æž©åºŠã«å ç±ããŠæº¶è§£ãã
次ãã§ç±çç¶æ ãä¿ã¡ãªãã溶液ããéãæŽã«ã
éã氷济äžã§ïŒæéæ¹æããã³å·åŽãçµæ¶åãã
ããã次ãã§çæç©ããšã¿ããŒã«ïŒÃ30mlã§æŽæµ
ã宀枩ã§ç©ºæ°äžã§ä¹Ÿç¥ãããæ¯æ¶²ãæžå§äžïŒïŒã
5kPaïŒã§æåã®å®¹ç©ã®çŽååãŸã§èžçºããã次
ãã§ïŒâã«å·åŽãçæç©ã®ç¬¬äºã®åç©«ç©ãåŸãã
å šäœã®åçã¯ãå¡©åºã®ïŒïŒïŒé ç³å¡©é žã®125ïœ
ïŒ90ïŒ ïŒã§ãããå¡©ã¯228ã231âã§è解ïŒå解ã
䌎ãïŒããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ããšãïŒïŒïŒïŒâïŒâïŒâãã³ãŸããšãã³
âïŒïŒ9HïŒâãªã³ãå¡©åïŒâã¡ãã«âïŒâãããª
ãžã«ãã°ãã·ãŠã ãšããã©ããããã©ã³äžã§åå¿
ãããåŒç¶ãåŸããã次åŒïŒ ãæããïŒâïŒïŒâã¡ãã«âïŒâãããªãžã«ïŒâ
ïŒïŒïŒâãžãããããšãïŒïŒïŒïŒâïŒâïŒâã
ã³ãŸããšãã³âïŒâãªãŒã«ãé žè§Šåªã®è±æ°Žåå¿ã«
ããã次åŒïŒ ãæããïŒâïŒïŒâã¡ãã«âïŒâãããªãžãªãã³ïŒ
âïŒïŒïŒâãžãããããšãïŒïŒïŒïŒâïŒâïŒâ
ãã³ãŸããšãã³ããã³ãã®ïŒïŒïŒé ç³é žå¡©ã補é
ããæ¹æ³ã§ãã€ãŠãåæã«åŸããã次åŒïŒ ã®ïŒâïŒïŒâã¡ãã«âïŒâãããªãžã«ïŒããšã
ïŒïŒïŒïŒâïŒâïŒâãã³ãŸããšãã³âïŒïŒ9HïŒâ
ãªã³ããšã¿ããŒã«ã§æœåºããããšã«ãããããå«
ãŸããªãããã«ããåŒã®çŽç²ãªã¢ã«ã³ãŒã«ãäž
溶çæç©è³ªãšããŠåé¢ã次ãã§åèšè±æ°Žåå¿ã«å§
ãã次ãã§åŸãããåŒã®ç²è£œå¡©åºããšã¿ããŒã«
ããçµæ¶åããããšã«ããåŒã®åèšã±ãã³ã®æ®
çç©ãå«ãŸããªãããã«ãããããåŸææã«ãã
åŒã®çŽç²ãªå¡©åºãæ°Žæ§ãšã¿ããŒã«äžïŒïŒïŒé ç³
é žã§äžåããããšã«ããåèšå¡©ã«å€æããããšã
ç¹åŸŽãšãããåèšè£œæ³ã
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS5715-82 | 1982-07-29 | ||
| CS825715A CS231083B1 (en) | 1982-07-29 | 1982-07-29 | Processing method of 4-(1-methyl-4-piperidyliden)-4,9-dihydrothieno (2,3-c)-2-benzothiepine and its hydrogen-(p-tartarate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5942389A JPS5942389A (ja) | 1984-03-08 |
| JPH0367072B2 true JPH0367072B2 (ja) | 1991-10-21 |
Family
ID=5402541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58137917A Granted JPS5942389A (ja) | 1982-07-29 | 1983-07-29 | ïŒâïŒïŒâã¡ãã«âïŒâãããªãžãªãã³ïŒâïŒïŒïŒâãžãããããšãïŒïŒïŒïŒâïœïŒâïŒâãã³ãŸããšãã³ããã³ãã®é ç³é žå¡©ã®è£œæ³ |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5942389A (ja) |
| AT (1) | AT380257B (ja) |
| BE (1) | BE897185A (ja) |
| CA (1) | CA1191138A (ja) |
| CH (1) | CH655117A5 (ja) |
| CS (1) | CS231083B1 (ja) |
| DE (1) | DE3327138A1 (ja) |
| DK (1) | DK309183A (ja) |
| FI (1) | FI73686C (ja) |
| FR (1) | FR2531086B1 (ja) |
| GB (1) | GB2124219B (ja) |
| IT (1) | IT1194342B (ja) |
| NL (1) | NL8302597A (ja) |
| SE (1) | SE451841B (ja) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6414153A (ja) * | 1963-12-10 | 1965-06-11 |
-
1982
- 1982-07-29 CS CS825715A patent/CS231083B1/cs unknown
-
1983
- 1983-06-30 BE BE0/211099A patent/BE897185A/fr not_active IP Right Cessation
- 1983-06-30 GB GB08317767A patent/GB2124219B/en not_active Expired
- 1983-07-05 DK DK309183A patent/DK309183A/da not_active Application Discontinuation
- 1983-07-19 AT AT0264283A patent/AT380257B/de not_active IP Right Cessation
- 1983-07-20 NL NL8302597A patent/NL8302597A/nl not_active Application Discontinuation
- 1983-07-22 SE SE8304102A patent/SE451841B/sv not_active IP Right Cessation
- 1983-07-26 IT IT22237/83A patent/IT1194342B/it active
- 1983-07-26 FR FR8312365A patent/FR2531086B1/fr not_active Expired
- 1983-07-27 CA CA000433350A patent/CA1191138A/en not_active Expired
- 1983-07-27 DE DE19833327138 patent/DE3327138A1/de active Granted
- 1983-07-28 FI FI832728A patent/FI73686C/fi not_active IP Right Cessation
- 1983-07-28 CH CH4150/83A patent/CH655117A5/de not_active IP Right Cessation
- 1983-07-29 JP JP58137917A patent/JPS5942389A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IT1194342B (it) | 1988-09-14 |
| CS571582A1 (en) | 1984-02-13 |
| FR2531086B1 (fr) | 1986-03-21 |
| DK309183A (da) | 1984-01-30 |
| BE897185A (fr) | 1983-10-17 |
| GB2124219A (en) | 1984-02-15 |
| FR2531086A1 (fr) | 1984-02-03 |
| NL8302597A (nl) | 1984-02-16 |
| CS231083B1 (en) | 1984-09-17 |
| ATA264283A (de) | 1985-09-15 |
| FI832728A0 (fi) | 1983-07-28 |
| GB2124219B (en) | 1985-11-20 |
| FI832728A7 (fi) | 1984-01-30 |
| DE3327138A1 (de) | 1984-02-09 |
| AT380257B (de) | 1986-05-12 |
| IT8322237A0 (it) | 1983-07-26 |
| IT8322237A1 (it) | 1985-01-26 |
| GB8317767D0 (en) | 1983-08-03 |
| CH655117A5 (de) | 1986-03-27 |
| FI73686C (fi) | 1987-11-09 |
| DE3327138C2 (ja) | 1989-05-03 |
| FI73686B (fi) | 1987-07-31 |
| SE451841B (sv) | 1987-11-02 |
| CA1191138A (en) | 1985-07-30 |
| SE8304102D0 (sv) | 1983-07-22 |
| DK309183D0 (da) | 1983-07-05 |
| SE8304102L (sv) | 1984-01-30 |
| JPS5942389A (ja) | 1984-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4272541A (en) | 7,8 and 7-8 Substituted 4,5α-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them | |
| EP2300479B1 (en) | Nalmefene hydrochloride dihydrate | |
| Sundberg et al. | Diels-Alder adducts of 1-benzenesulfonylindole-2-acrylates and 1-(alkoxycarbonyl)-1, 2-dihydropyridines. Intermediates for synthesis of iboga alkaloid analogs | |
| JPS6152155B2 (ja) | ||
| KR20160003899A (ko) | ë§í¬ë¡€ëŠ¬ë ê³ ì²Žì íí | |
| JPS6160830B2 (ja) | ||
| SI9720038A (sl) | Polimorfi donepezil hidroklorida in postopek izdelave | |
| NO753062L (ja) | ||
| EP0008249A2 (fr) | Dérivés de fluorÚnes et fluoranthÚnes, leur procédé de préparation et leur application en thérapeutique | |
| JPH09510222A (ja) | ïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒïœâïŒâãã³ãŸã¢ãŒãã³ååç©ã®é žä»å å¡© | |
| JPH08504830A (ja) | ã¹ããã¹ã¿ãã«ã°ãªã³ã·ãçµæ¶è³ªäžæ°Žå¡© | |
| JPS62907B2 (ja) | ||
| Witkop et al. | Aspidospermine. II | |
| JP3172543B2 (ja) | ïŒïŒïŒïŒïŒâãžãã«ãšãã«ãã¡ãã³ã®æ°èŠã®èªå°äœããããã®è£œé æ¹æ³åã³åŸãããæ°èŠã®äžéäœããããã®è¬å€ãšããŠã®äœ¿çšäžŠã³ã«ããããå«æããçµæç© | |
| US4927837A (en) | Derivatives of 3-piperidine carbaldehyde oxime and their use as medicaments | |
| CH630629A5 (fr) | Derives de la morphine, leur procede de preparation et leur application comme medicament. | |
| IE49906B1 (en) | New indole derivatives,process for preparing them,and pharmaceutical compositions containing them | |
| JPH0367072B2 (ja) | ||
| CN107778234A (zh) | äžç§ç¥ç»èèé»æ»åäžéŽäœçå¶å€æ¹æ³ | |
| Koniuszy et al. | Erythrina Alkaloids. XVI. Studies on the Constitution of Erysodine, Erysovine and Erysopine | |
| Small et al. | The Desoxymorphines1 | |
| US20050288330A1 (en) | Process for producing a polymorphic form of (1-Benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride) | |
| WO2004099142A1 (en) | Hydrobromide salt of benzyl-piperidylmethyl-indanone and its polymorphs | |
| US3488354A (en) | Substituted 7,8 - dihydro - 6-hydroxy-6,14-endo (etheno or ethano)codide - 7-ketones and substituted 7,8 - dihydro-6-hydroxy-6,14-endo (etheno or ethano) morphide-7-ketones | |
| US20070123565A1 (en) | Donepezil Hydrochloride Form VI |